Federation Des Caisses Desjardins Du Quebec Iovance Biotherapeutics, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 1,650 shares of IOVA stock, worth $14,173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,650Holding current value
$14,173% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
313Shares Held
242MCall Options Held
1.78MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA27.3MShares$235 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$229 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$206 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$182 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$113 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.36B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...